US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist
  • 0.916
  • -0.005-0.59%
Close Dec 20 16:00 ET
  • 0.958
  • +0.043+4.64%
Post 20:01 ET
156.31MMarket Cap-4.36P/E (TTM)

Seres Therapeutics Key Stats

Seres Therapeutics Q3 2024 Earnings Date

Currency:USDNov 13, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
25.83M
0
-25.83M
Miss Est.
+8233.33%
--
-100.00%
EPS
-0.08
0.58
+0.66
Beat Est.
+78.94%
+256.76%
+844.54%
Hold

Dec 21, 2024

Seres Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.500M--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 25.833M--
Aug 13, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 250.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.500M--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 25.833M--
Aug 13, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 250.000K--

Unlock Free Earnings Estimates

Seres Therapeutics Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 21, 2024

Hold

  • Buy

    50.00%
  • Hold

    0.00%
  • Sell

    50.00%

Price Target

No Data